Predictive Oncology Reports Second Quarter 2020 Financial Results, Provides Business Update
Increases Readiness for Commercialization with Expanded Portfolio of Solutions for Precision Medicine NEW YORK, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“ …